Haemonetics (HAE) Stock Forecast for 2024–2028. Sell or Buy Prediction







Maximizing Profits: When is the Right Time to Sell Your Business?

April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?

Selling a business can be a momentous decision filled with many considerations and uncertainties. As an entrepreneur, this also symbolizes your years of…
Improve Your Financial Status: A How-To Guide

April 12, 2024 Improve Your Financial Status: A How-To Guide

Navigating through the complexities of personal finance can often feel like walking through a maze blindfolded. This guide is crafted especially for you,…
How ZIM Integrated Container Tracking is Revolutionizing Global Trade

April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade

Have you ever wondered how your online shopping packages get to you? A big part of the answer is ZIM Integrated Container Tracking.…
6 Best Growth Stocks To Buy Now According to Metatrader 5

March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5

One of the reasons investors prefer growth stocks is that they are expected to perform better than other companies in terms of sales…

Haemonetics (HAE) Stock Forecast for 2024–2028. Sell or Buy?

Updated: July 23, 2024 (04:38)

Sector: Healthcare

The share price of Haemonetics Corporation (HAE) now

Latest session on the 22nd of July for
Haemonetics Corporation is positive
Trading Volume: 427982
Open: 89.5 /  High: 90.68 /  Low: 88.52
What analysts predict: $113.29
52-week High/Low: $97.97 / $70.74

50/200 Day Moving Average: $88.05 / $84.53

This figure corresponds to the Average Price over the previous 50/200 days. For Haemonetics stocks, the 50-day moving average is the support level today.

For Haemonetics stocks, the 200-day moving average is the support level today.

Are you interested in Haemonetics Corporation stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Haemonetics stock price in 2024, 2025, 2026, 2027, 2028. How much will one Haemonetics share be worth in 2024 - 2028?

When should I take profit in Haemonetics stock? When should I record a loss on Haemonetics stock? What are analysts' forecasts for Haemonetics stock? What is the future of Haemonetics stock? We forecast Haemonetics stock performance using neural networks based on historical data on Haemonetics stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Haemonetics stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2024, 2025, 2026, 2027 and 2028) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Haemonetics shares. This happens once a day.


Historical and forecast chart of Haemonetics stock

The chart below shows the historical price of Haemonetics stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Haemonetics stock price can be found in the table below.

Long-term forecasts by years.

Haemonetics Corporation is a medical company offering hematology products and solutions. It operates through three segments: Plasma, Blood Center and Hospital. The company offers automated plasma collection devices, related disposable products and software, including NexSys PCS and PCS2 plasmapheresis equipment, as well as related disposable and intravenous solutions, as well as integrated information technology platforms for plasma customers to manage their donors, operations and supply chain; and the NexLynk DMS Donor Management System.

Haemonetics daily forecast for a month

Date Target Pes. Opt. Vol., %
Jul 25 92.10 90.83 93.57 3.02
Jul 26 91.67 90.79 92.66 2.06
Jul 27 90.39 89.30 91.22 2.15
Jul 28 91.04 90.62 91.84 1.35
Jul 29 91.46 90.25 92.25 2.21
Jul 30 91.04 90.38 92.06 1.85
Jul 31 91.51 90.08 91.95 2.07
Aug 01 91.38 90.62 92.17 1.71
Aug 02 91.95 91.38 92.72 1.47
Aug 03 91.75 90.44 93.01 2.84
Aug 04 90.15 88.82 91.05 2.52
Aug 05 91.94 90.50 92.52 2.23
Aug 06 92.84 91.74 93.23 1.62
Aug 07 94.49 94.02 95.09 1.15
Aug 08 94.47 93.87 95.36 1.59
Aug 09 94.34 93.55 94.96 1.51
Aug 10 93.62 92.80 94.74 2.10
Aug 11 93.15 92.39 93.75 1.47
Aug 12 93.15 91.96 93.99 2.21
Aug 13 91.29 90.18 91.87 1.88
Aug 14 90.38 89.73 91.61 2.10
Aug 15 90.94 90.01 92.05 2.26
Aug 16 91.45 90.13 92.86 3.02
Aug 17 92.80 91.65 94.27 2.86
Aug 18 93.97 92.67 95.21 2.74
Aug 19 95.45 93.95 95.99 2.17
Aug 20 95.02 93.55 95.59 2.17
Aug 21 95.00 93.69 96.42 2.92
Aug 22 93.50 92.21 94.75 2.76
Aug 23 93.23 92.34 94.15 1.96

Haemonetics Daily Price Targets


Haemonetics Stock Forecast 07-25-2024.

Forecast target price for 07-25-2024: $92.10.
Positive dynamics for Haemonetics shares will prevail with possible volatility of 2.933%.
Pessimistic target level: 90.83
Optimistic target level: 93.57

Haemonetics Stock Forecast 07-26-2024.

Forecast target price for 07-26-2024: $91.67.
Negative dynamics for Haemonetics shares will prevail with possible volatility of 2.018%.
Pessimistic target level: 90.79
Optimistic target level: 92.66

Haemonetics Stock Forecast 07-27-2024.

Forecast target price for 07-27-2024: $90.39.
Negative dynamics for Haemonetics shares will prevail with possible volatility of 2.101%.
Pessimistic target level: 89.30
Optimistic target level: 91.22

Haemonetics Stock Forecast 07-28-2024.

Forecast target price for 07-28-2024: $91.04.
Positive dynamics for Haemonetics shares will prevail with possible volatility of 1.328%.
Pessimistic target level: 90.62
Optimistic target level: 91.84

Haemonetics Stock Forecast 07-29-2024.

Forecast target price for 07-29-2024: $91.46.
Positive dynamics for Haemonetics shares will prevail with possible volatility of 2.161%.
Pessimistic target level: 90.25
Optimistic target level: 92.25

Haemonetics Stock Forecast 07-30-2024.

Forecast target price for 07-30-2024: $91.04.
Negative dynamics for Haemonetics shares will prevail with possible volatility of 1.820%.
Pessimistic target level: 90.38
Optimistic target level: 92.06

HAE (HAE) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Aug. 92.10 88.05 95.97 8.25
Sep. 94.40 92.42 99.12 6.76
Oct. 89.68 83.05 92.11 9.83
Nov. 89.68 84.66 92.91 8.88
Dec. 88.43 85.51 92.41 7.46

Haemonetics forecast for this year


Haemonetics Stock Prediction for Aug 2024

An uptrend is forecast for this month with an optimal target price of $92.1017. Pessimistic: $88.05. Optimistic: $95.97


Haemonetics Stock Prediction for Sep 2024

An uptrend is forecast for this month with an optimal target price of $94.4043. Pessimistic: $92.42. Optimistic: $99.12


Haemonetics Stock Prediction for Oct 2024

An downtrend is forecast for this month with an optimal target price of $89.6841. Pessimistic: $83.05. Optimistic: $92.11


Haemonetics Stock Prediction for Nov 2024

An downtrend is forecast for this month with an optimal target price of $89.6841. Pessimistic: $84.66. Optimistic: $92.91


Haemonetics Stock Prediction for Dec 2024

An downtrend is forecast for this month with an optimal target price of $88.4285. Pessimistic: $85.51. Optimistic: $92.41



Haemonetics (HAE) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 95.24 89.71 97.43 7.92
Feb 93.24 86.06 96.31 10.65
Mar 92.58 87.12 99.44 12.38
Apr 93.88 89.75 96.04 6.55
May 92.66 88.31 98.41 10.26
Jun 91.46 84.96 96.85 12.28
Jul 90.63 85.47 94.35 9.41
Aug 86.28 79.98 91.80 12.88
Sep 88.44 83.66 90.21 7.25
Oct 89.59 82.60 94.34 12.44
Nov 85.20 78.72 90.99 13.48
Dec 81.20 78.52 84.61 7.20

Haemonetics (HAE) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 86.96 83.31 90.61 8.06
Feb 88.79 82.22 93.58 12.14
Mar 80.88 76.35 87.35 12.59
Apr 79.59 73.70 83.49 11.73
May 80.94 75.03 84.59 11.29
Jun 84.42 82.40 87.63 5.97
Jul 88.56 82.27 90.77 9.37
Aug 89.62 83.26 93.92 11.35
Sep 92.58 88.88 96.93 8.31
Oct 88.41 85.67 94.96 9.78
Nov 86.65 79.80 88.73 10.06
Dec 85.35 79.88 88.33 9.57

Haemonetics (HAE) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 89.10 84.47 94.54 10.65
Feb 81.71 79.17 85.71 7.63
Mar 82.85 77.88 86.08 9.53
Apr 88.40 85.84 91.94 6.63
May 95.56 89.92 103.02 12.71
Jun 91.93 85.04 95.15 10.63
Jul 90.18 85.67 94.96 9.78
Aug 93.97 89.37 96.79 7.67
Sep 94.35 91.23 96.71 5.66
Oct 90.20 86.77 92.81 6.51
Nov 88.12 84.07 94.38 10.92
Dec 91.12 87.38 92.94 5.98

Haemonetics (HAE) Monthly Stock Prediction for 2028

Month Target Pes. Opt. Vol., %
Jan 89.11 85.19 91.96 7.36
Feb 87.51 84.53 90.83 6.94
Mar 85.15 83.44 91.79 9.09
Apr 89.57 85.72 91.81 6.63
May 92.08 87.02 97.61 10.85
Jun 100.37 97.06 108.30 10.38
Jul 97.06 90.75 102.20 11.21
Aug 98.12 92.92 100.19 7.25
Sep 94.00 88.83 97.76 9.13
Oct 90.71 88.54 96.79 8.53
Nov 90.17 82.96 96.57 14.10
Dec 94.14 87.92 100.35 12.38

Haemonetics information and performance

Haemonetics Address

125 SUMMER STREET, BOSTON, MA, US

Market Capitalization: 4 521 069 000 $

Market capitalization of the Haemonetics Corporation is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of HAE shares in the company outstanding by the market price of one share.

EBITDA: 295 452 000 $

EBITDA of Haemonetics is earnings before interest, income tax and depreciation of assets.

PE Ratio: 38.75

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: 1.633

Price/earnings to growth

DPS: None

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: None

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: 2.29

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: -0.298
Quarterly Revenue Growth YOY: 0.128
Trailing PE: 38.75

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: 19.61

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 3.94

Enterprise Value (EV) /Revenue

EV To EBITDA: 18.98

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 50953000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A



Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.